María J Alonso

Author PubWeight™ 35.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ouabain treatment increases nitric oxide bioavailability and decreases superoxide anion production in cerebral vessels. J Hypertens 2008 1.39
2 Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. Hypertension 2009 1.14
3 The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci 2003 1.13
4 Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. Antioxid Redox Signal 2012 1.12
5 Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J Hypertens 2005 1.03
6 Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 2006 1.00
7 Alterations in phenylephrine-induced contractions and the vascular expression of Na+,K+-ATPase in ouabain-induced hypertension. Br J Pharmacol 2002 0.98
8 Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats. J Pharmacol Exp Ther 2007 0.97
9 Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules. Biomacromolecules 2009 0.96
10 Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries. Am J Physiol Heart Circ Physiol 2004 0.95
11 Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur J Pharm Sci 2003 0.94
12 Vascular effects of the Mangifera indica L. extract (Vimang). Eur J Pharmacol 2004 0.93
13 Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress. J Hypertens 2012 0.92
14 Neurogenic nitric oxide release increases in mesenteric arteries from ouabain hypertensive rats. J Hypertens 2004 0.92
15 Vasodilator effects of peptides derived from egg white proteins. Regul Pept 2007 0.92
16 Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. Am J Physiol Heart Circ Physiol 2002 0.91
17 Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats. Am J Physiol Heart Circ Physiol 2006 0.89
18 Chronic exposure to low doses of mercury impairs sperm quality and induces oxidative stress in rats. J Toxicol Environ Health A 2014 0.87
19 New roles for old pathways? A circuitous relationship between reactive oxygen species and cyclo-oxygenase in hypertension. Clin Sci (Lond) 2014 0.85
20 Ouabain-induced hypertension alters the participation of endothelial factors in alpha-adrenergic responses differently in rat resistance and conductance mesenteric arteries. Br J Pharmacol 2004 0.85
21 Ouabain treatment changes the role of endothelial factors in rat resistance arteries. Eur J Pharmacol 2008 0.83
22 Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles. Cornea 2010 0.83
23 Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is dependent on reactive oxygen species. Br J Pharmacol 2011 0.82
24 p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats. J Hypertens 2009 0.82
25 Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain. Br J Pharmacol 2004 0.82
26 Hypertension alters the participation of contractile prostanoids and superoxide anions in lipopolysaccharide effects on small mesenteric arteries. Life Sci 2002 0.81
27 High glucose enhances inducible nitric oxide synthase expression. Role of protein kinase C-betaII. Eur J Pharmacol 2006 0.81
28 Losartan and tempol treatments normalize the increased response to hydrogen peroxide in resistance arteries from hypertensive rats. J Hypertens 2009 0.80
29 Measurements of nitric oxide concentration and hyporeactivity in rat superior mesenteric artery exposed to endotoxin. Cardiovasc Res 2004 0.80
30 Angiotensin II differentially modulates cyclooxygenase-2, microsomal prostaglandin E2 synthase-1 and prostaglandin I2 synthase expression in adventitial fibroblasts exposed to inflammatory stimuli. J Hypertens 2011 0.80
31 Alterations of the nitric oxide pathway in cerebral arteries from spontaneously hypertensive rats. J Cardiovasc Pharmacol 2002 0.79
32 Apocynin prevents vascular effects caused by chronic exposure to low concentrations of mercury. PLoS One 2013 0.79
33 Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy. J Control Release 2013 0.79
34 Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules. Macromol Biosci 2008 0.77
35 Small artery remodeling in obesity and insulin resistance. Curr Vasc Pharmacol 2014 0.77
36 Impairment of fetal endothelium-dependent relaxation in a rat model of preeclampsia by chronic nitric oxide synthase inhibition. J Soc Gynecol Investig 2004 0.77
37 Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function. Br J Pharmacol 2012 0.76
38 c-Src, ERK1/2 and Rho kinase mediate hydrogen peroxide-induced vascular contraction in hypertension: role of TXA2, NAD(P)H oxidase and mitochondria. J Hypertens 2015 0.76
39 Postnatal maturation in nitric oxide-induced pulmonary artery relaxation involving cyclooxygenase-1 activity. Am J Physiol Lung Cell Mol Physiol 2002 0.76
40 Administration of N(omega)-L-arginine methyl ester (L-NAME) impairs endothelium-dependent relaxation in gravid but not nongravid rats. J Soc Gynecol Investig 2003 0.76
41 A prolonged, perplexing pyrexia. Am J Med 2009 0.75
42 Reproductive dysfunction after mercury exposure at low levels: evidence for a role of glutathione peroxidase (GPx) 1 and GPx4 in male rats. Reprod Fertil Dev 2016 0.75
43 [5-year-old yellowish-brownish tumor of the back]. Actas Dermosifiliogr 2006 0.75